Skip to main content
OpenTrials

Clinical trial condition

Recurrent/Refractory Childhood Hodgkin Lymphoma

Explore clinical trials studying Recurrent/Refractory Childhood Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

31 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent/Refractory Childhood Hodgkin Lymphoma trial results

Completed

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

NCT01748721

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California San Francisco Medical Center - Parnassus San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Completed

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01231919

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, +130 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Childrens Hospital of Orange County Orange, California, United States
  • University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 25 locations
View Trial Details
Completed

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

NCT00994500

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +90 more
Locations
  • Childrens Memorial Hospital Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions